ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA

Overview Fund Activity

21 hedge funds and large institutions have $1.24M invested in Oruka Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$266K
2
Deutsche Bank
2
Deutsche Bank
Germany
$175K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$50K
4
PAM
4
Panagora Asset Management
Massachusetts
$44K
5
VF
5
Virtu Financial
New York
$34K

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$0
2
Franklin Resources
2
Franklin Resources
California
$0
3
VMI
3
VHCP Management II
New York
$0
4
SM
4
Sabby Management
Florida
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$18K
Name Market Value Shares Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$0 47 +47 New
Barclays
27
Barclays
United Kingdom
$0 73 +73 New
Morgan Stanley
28
Morgan Stanley
New York
$0 250 +245 +4,900%
1
2